Christopher Boerner - Chief Executive Officer, Director at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Christopher Boerner - trading volume in the past year for Bristol Myers Squibb Co

Holdings reported by Christopher Boerner for Bristol Myers Squibb Co

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 125K $7.92M $63.11 Mar 10, 2025 Direct
Common Stock, $0.10 par value 101K $5.44M $53.79 Mar 10, 2024 Direct
Market Share Units 97.1K $5.14M $52.99 Mar 10, 2025 Direct Common Stock, $0.10 par value
Performance Shares 146K Mar 10, 2025 Direct Common Stock, $0.10 par value

Transactions reported by Christopher Boerner for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.